ArticleBMC nutrition2025
Health risk assessment and determination of bisphenol A and aflatoxin M1 in infant formula.
Article in BMC nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Health Risk Assessment of Dietary Chemical Exposures: A Comprehensive Review.Foods (Basel, Switzerland) · 2025Review
- Bisphenol A Levels in Pasteurized Milk Marketed in Plastic Packaging and Associated Health Risk Assessment: A Pilot Study.Journal of xenobiotics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBisphenol A (BPA) is one of the chemical compounds used in food packaging, so it can migrate from the packaging into food. Also, environmental pollution of this compound is high due to its high use. Therefore, it may enter food chains through the environment. Aflatoxin M1 (AFM1) is one of the common mycotoxins in milk. Its presence has been reported worldwide. Infant formula is an alternative to human milk. The main ingredient of this product is cow's milk.
aimsThis study aimed to investigate the levels and risk assessment of BPA and aflatoxin M1 in infant formula.
methodsSamples were purchased from 7 leading brands of infant formula in pharmacies. The samples were extracted according to common protocols and then injected into HPLC and analyzed with a fluorescence detector for both contaminants.
resultsBPA wasn't detected in infant formula samples, but the presence of AFM1was confirmed in 11% of the samples. Of course, there is no risk in this regard with the risk assessment.
conclusionInfant formula samples are not of concern for infants in terms of BPA and aflatoxin M1. However, continuous monitoring is recommended for this product.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.